EU Lawmakers Approve Rules to Strengthen Safety of Children's Meds

International Pharmaceutical Regulatory Monitor
KEYWORDS EU / Regulations
A A

Under new regulations passed by the European Parliament, drug companies that research the safety and efficacy of their products in children will get a six-month patent extension.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $10.00